img

Global High Affinity Nerve Growth Factor Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global High Affinity Nerve Growth Factor Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

High Affinity Nerve Growth Factor Receptor report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global High Affinity Nerve Growth Factor Receptor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Bile Duct Cancer and Papillary Thyroid Cancer are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for High Affinity Nerve Growth Factor Receptor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, High Affinity Nerve Growth Factor Receptor key companies include Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc, Daiichi Sankyo Co Ltd, Dompe Farmaceutici SpA, Genzyme Corp, Handok Inc, Ignyta Inc and Loxo Oncology Inc, etc. Array BioPharma Inc, Astellas Pharma Inc, AstraZeneca Plc are top 3 players and held % share in total in 2022.
High Affinity Nerve Growth Factor Receptor can be divided into ASP-7962, AZD-7451, BNN-27 and Cenegermin, etc. ASP-7962 is the mainstream product in the market, accounting for % share globally in 2022.
High Affinity Nerve Growth Factor Receptor is widely used in various fields, such as Bile Duct Cancer, Papillary Thyroid Cancer, Low Back Pain and Lung Cancer, etc. Bile Duct Cancer provides greatest supports to the High Affinity Nerve Growth Factor Receptor industry development. In 2022, global % share of High Affinity Nerve Growth Factor Receptor went into Bile Duct Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global High Affinity Nerve Growth Factor Receptor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Array BioPharma Inc
Astellas Pharma Inc
AstraZeneca Plc
Daiichi Sankyo Co Ltd
Dompe Farmaceutici SpA
Genzyme Corp
Handok Inc
Ignyta Inc
Loxo Oncology Inc
Merck & Co Inc
Nerviano Medical Sciences Srl
Plexxikon Inc
Proximagen Ltd
Rottapharm Biotech Srl
Sienna Biopharmaceuticals Inc
Tiziana Life Sciences Plc
Segment by Type
ASP-7962
AZD-7451
BNN-27
Cenegermin
CRB-0089
Others

Segment by Application


Bile Duct Cancer
Papillary Thyroid Cancer
Low Back Pain
Lung Cancer
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the High Affinity Nerve Growth Factor Receptor market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, High Affinity Nerve Growth Factor Receptor introduction, etc. High Affinity Nerve Growth Factor Receptor Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12QYResearch’s Conclusions of High Affinity Nerve Growth Factor Receptor market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Market Overview of High Affinity Nerve Growth Factor Receptor
1.1 High Affinity Nerve Growth Factor Receptor Market Overview
1.1.1 High Affinity Nerve Growth Factor Receptor Product Scope
1.1.2 High Affinity Nerve Growth Factor Receptor Market Status and Outlook
1.2 Global High Affinity Nerve Growth Factor Receptor Market Size Overview by Region 2018 VS 2022 VS 2034
1.3 Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2034)
1.4 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Region (2018-2024)
1.5 Global High Affinity Nerve Growth Factor Receptor Market Size Forecast by Region (2024-2034)
1.6 Key Regions, High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
1.6.1 North America High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
1.6.2 Europe High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
1.6.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
1.6.4 Latin America High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
1.6.5 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size (2018-2034)
2 High Affinity Nerve Growth Factor Receptor Market by Type
2.1 Introduction
2.1.1 ASP-7962
2.1.2 AZD-7451
2.1.3 BNN-27
2.1.4 Cenegermin
2.1.5 CRB-0089
2.1.6 Others
2.2 Global High Affinity Nerve Growth Factor Receptor Market Size by Type: 2018 VS 2022 VS 2034
2.2.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Type (2018-2024)
2.2.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Type (2018-2034)
2.3.2 Europe High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Type (2018-2034)
2.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Type (2018-2034)
2.3.4 Latin America High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Type (2018-2034)
2.3.5 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Type (2018-2034)
3 High Affinity Nerve Growth Factor Receptor Market Overview by Application
3.1 Introduction
3.1.1 Bile Duct Cancer
3.1.2 Papillary Thyroid Cancer
3.1.3 Low Back Pain
3.1.4 Lung Cancer
3.1.5 Others
3.2 Global High Affinity Nerve Growth Factor Receptor Market Size by Application: 2018 VS 2022 VS 2034
3.2.1 Global High Affinity Nerve Growth Factor Receptor Historic Market Size by Application (2018-2024)
3.2.2 Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Application (2018-2034)
3.3.2 Europe High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Application (2018-2034)
3.3.3 Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Application (2018-2034)
3.3.4 Latin America High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Application (2018-2034)
3.3.5 Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Breakdown by Application (2018-2034)
4 High Affinity Nerve Growth Factor Receptor Competition Analysis by Players
4.1 Global High Affinity Nerve Growth Factor Receptor Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2022)
4.3 Date of Key Players Enter into High Affinity Nerve Growth Factor Receptor Market
4.4 Global Top Players High Affinity Nerve Growth Factor Receptor Headquarters and Area Served
4.5 Key Players High Affinity Nerve Growth Factor Receptor Product Solution and Service
4.6 Competitive Status
4.6.1 High Affinity Nerve Growth Factor Receptor Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Array BioPharma Inc
5.1.1 Array BioPharma Inc Profile
5.1.2 Array BioPharma Inc Main Business
5.1.3 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.1.4 Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.1.5 Array BioPharma Inc Recent Developments
5.2 Astellas Pharma Inc
5.2.1 Astellas Pharma Inc Profile
5.2.2 Astellas Pharma Inc Main Business
5.2.3 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.2.4 Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.2.5 Astellas Pharma Inc Recent Developments
5.3 AstraZeneca Plc
5.3.1 AstraZeneca Plc Profile
5.3.2 AstraZeneca Plc Main Business
5.3.3 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.3.4 AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.3.5 Daiichi Sankyo Co Ltd Recent Developments
5.4 Daiichi Sankyo Co Ltd
5.4.1 Daiichi Sankyo Co Ltd Profile
5.4.2 Daiichi Sankyo Co Ltd Main Business
5.4.3 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.4.4 Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.4.5 Daiichi Sankyo Co Ltd Recent Developments
5.5 Dompe Farmaceutici SpA
5.5.1 Dompe Farmaceutici SpA Profile
5.5.2 Dompe Farmaceutici SpA Main Business
5.5.3 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.5.4 Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.5.5 Dompe Farmaceutici SpA Recent Developments
5.6 Genzyme Corp
5.6.1 Genzyme Corp Profile
5.6.2 Genzyme Corp Main Business
5.6.3 Genzyme Corp High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.6.4 Genzyme Corp High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.6.5 Genzyme Corp Recent Developments
5.7 Handok Inc
5.7.1 Handok Inc Profile
5.7.2 Handok Inc Main Business
5.7.3 Handok Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.7.4 Handok Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.7.5 Handok Inc Recent Developments
5.8 Ignyta Inc
5.8.1 Ignyta Inc Profile
5.8.2 Ignyta Inc Main Business
5.8.3 Ignyta Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.8.4 Ignyta Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.8.5 Ignyta Inc Recent Developments
5.9 Loxo Oncology Inc
5.9.1 Loxo Oncology Inc Profile
5.9.2 Loxo Oncology Inc Main Business
5.9.3 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.9.4 Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.9.5 Loxo Oncology Inc Recent Developments
5.10 Merck & Co Inc
5.10.1 Merck & Co Inc Profile
5.10.2 Merck & Co Inc Main Business
5.10.3 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.10.4 Merck & Co Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.10.5 Merck & Co Inc Recent Developments
5.11 Nerviano Medical Sciences Srl
5.11.1 Nerviano Medical Sciences Srl Profile
5.11.2 Nerviano Medical Sciences Srl Main Business
5.11.3 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.11.4 Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.11.5 Nerviano Medical Sciences Srl Recent Developments
5.12 Plexxikon Inc
5.12.1 Plexxikon Inc Profile
5.12.2 Plexxikon Inc Main Business
5.12.3 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.12.4 Plexxikon Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.12.5 Plexxikon Inc Recent Developments
5.13 Proximagen Ltd
5.13.1 Proximagen Ltd Profile
5.13.2 Proximagen Ltd Main Business
5.13.3 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.13.4 Proximagen Ltd High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.13.5 Proximagen Ltd Recent Developments
5.14 Rottapharm Biotech Srl
5.14.1 Rottapharm Biotech Srl Profile
5.14.2 Rottapharm Biotech Srl Main Business
5.14.3 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.14.4 Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.14.5 Rottapharm Biotech Srl Recent Developments
5.15 Sienna Biopharmaceuticals Inc
5.15.1 Sienna Biopharmaceuticals Inc Profile
5.15.2 Sienna Biopharmaceuticals Inc Main Business
5.15.3 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.15.4 Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.15.5 Sienna Biopharmaceuticals Inc Recent Developments
5.16 Tiziana Life Sciences Plc
5.16.1 Tiziana Life Sciences Plc Profile
5.16.2 Tiziana Life Sciences Plc Main Business
5.16.3 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
5.16.4 Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) & (2018-2024)
5.16.5 Tiziana Life Sciences Plc Recent Developments
6 North America
6.1 North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2034)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 High Affinity Nerve Growth Factor Receptor Market Dynamics
11.1 High Affinity Nerve Growth Factor Receptor Industry Trends
11.2 High Affinity Nerve Growth Factor Receptor Market Drivers
11.3 High Affinity Nerve Growth Factor Receptor Market Challenges
11.4 High Affinity Nerve Growth Factor Receptor Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market High Affinity Nerve Growth Factor Receptor Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2034
Table 2. Global High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Region (2018-2024)
Table 4. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size Share by Region (2024-2034)
Table 6. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million) by Type: 2018 VS 2022 VS 2034
Table 7. Global High Affinity Nerve Growth Factor Receptor Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2024)
Table 9. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2024-2034)
Table 11. North America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million) by Application: 2018 VS 2022 VS 2034
Table 22. Global High Affinity Nerve Growth Factor Receptor Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2024)
Table 24. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2024-2034)
Table 26. North America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global High Affinity Nerve Growth Factor Receptor Revenue (US$ Million) by Players (2018-2024)
Table 37. Global High Affinity Nerve Growth Factor Receptor Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in High Affinity Nerve Growth Factor Receptor as of 2022)
Table 39. Date of Key Players Enter into High Affinity Nerve Growth Factor Receptor Market
Table 40. Global High Affinity Nerve Growth Factor Receptor Key Players Headquarters and Area Served
Table 41. High Affinity Nerve Growth Factor Receptor Product Solution and Service
Table 42. Global High Affinity Nerve Growth Factor Receptor Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Array BioPharma Inc Basic Information List
Table 45. Array BioPharma Inc Description and Business Overview
Table 46. Array BioPharma Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 47. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Array BioPharma Inc (2018-2024)
Table 48. Array BioPharma Inc Recent Developments
Table 49. Astellas Pharma Inc Basic Information List
Table 50. Astellas Pharma Inc Description and Business Overview
Table 51. Astellas Pharma Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 52. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Astellas Pharma Inc (2018-2024)
Table 53. Astellas Pharma Inc Recent Developments
Table 54. AstraZeneca Plc Basic Information List
Table 55. AstraZeneca Plc Description and Business Overview
Table 56. AstraZeneca Plc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 57. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of AstraZeneca Plc (2018-2024)
Table 58. AstraZeneca Plc Recent Developments
Table 59. Daiichi Sankyo Co Ltd Basic Information List
Table 60. Daiichi Sankyo Co Ltd Description and Business Overview
Table 61. Daiichi Sankyo Co Ltd High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 62. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Daiichi Sankyo Co Ltd (2018-2024)
Table 63. Daiichi Sankyo Co Ltd Recent Developments
Table 64. Dompe Farmaceutici SpA Basic Information List
Table 65. Dompe Farmaceutici SpA Description and Business Overview
Table 66. Dompe Farmaceutici SpA High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 67. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Dompe Farmaceutici SpA (2018-2024)
Table 68. Dompe Farmaceutici SpA Recent Developments
Table 69. Genzyme Corp Basic Information List
Table 70. Genzyme Corp Description and Business Overview
Table 71. Genzyme Corp High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 72. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Genzyme Corp (2018-2024)
Table 73. Genzyme Corp Recent Developments
Table 74. Handok Inc Basic Information List
Table 75. Handok Inc Description and Business Overview
Table 76. Handok Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 77. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Handok Inc (2018-2024)
Table 78. Handok Inc Recent Developments
Table 79. Ignyta Inc Basic Information List
Table 80. Ignyta Inc Description and Business Overview
Table 81. Ignyta Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 82. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Ignyta Inc (2018-2024)
Table 83. Ignyta Inc Recent Developments
Table 84. Loxo Oncology Inc Basic Information List
Table 85. Loxo Oncology Inc Description and Business Overview
Table 86. Loxo Oncology Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 87. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Loxo Oncology Inc (2018-2024)
Table 88. Loxo Oncology Inc Recent Developments
Table 89. Merck & Co Inc Basic Information List
Table 90. Merck & Co Inc Description and Business Overview
Table 91. Merck & Co Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 92. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Merck & Co Inc (2018-2024)
Table 93. Merck & Co Inc Recent Developments
Table 94. Nerviano Medical Sciences Srl Basic Information List
Table 95. Nerviano Medical Sciences Srl Description and Business Overview
Table 96. Nerviano Medical Sciences Srl High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 97. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Nerviano Medical Sciences Srl (2018-2024)
Table 98. Nerviano Medical Sciences Srl Recent Developments
Table 99. Plexxikon Inc Basic Information List
Table 100. Plexxikon Inc Description and Business Overview
Table 101. Plexxikon Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 102. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Plexxikon Inc (2018-2024)
Table 103. Plexxikon Inc Recent Developments
Table 104. Proximagen Ltd Basic Information List
Table 105. Proximagen Ltd Description and Business Overview
Table 106. Proximagen Ltd High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 107. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Proximagen Ltd (2018-2024)
Table 108. Proximagen Ltd Recent Developments
Table 109. Rottapharm Biotech Srl Basic Information List
Table 110. Rottapharm Biotech Srl Description and Business Overview
Table 111. Rottapharm Biotech Srl High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 112. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Rottapharm Biotech Srl (2018-2024)
Table 113. Rottapharm Biotech Srl Recent Developments
Table 114. Sienna Biopharmaceuticals Inc Basic Information List
Table 115. Sienna Biopharmaceuticals Inc Description and Business Overview
Table 116. Sienna Biopharmaceuticals Inc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 117. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Sienna Biopharmaceuticals Inc (2018-2024)
Table 118. Sienna Biopharmaceuticals Inc Recent Developments
Table 119. Tiziana Life Sciences Plc Basic Information List
Table 120. Tiziana Life Sciences Plc Description and Business Overview
Table 121. Tiziana Life Sciences Plc High Affinity Nerve Growth Factor Receptor Products, Services and Solutions
Table 122. Revenue (US$ Million) in High Affinity Nerve Growth Factor Receptor Business of Tiziana Life Sciences Plc (2018-2024)
Table 123. Tiziana Life Sciences Plc Recent Developments
Table 124. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 125. North America High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 126. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 127. Europe High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 128. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 129. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2018-2024) & (US$ Million)
Table 130. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size by Region (2024-2034) & (US$ Million)
Table 131. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2018-2024)
Table 132. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2024-2034)
Table 133. Latin America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 134. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 135. Latin America High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 136. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 137. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2018-2024) & (US$ Million)
Table 138. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size by Country (2024-2034) & (US$ Million)
Table 139. High Affinity Nerve Growth Factor Receptor Market Trends
Table 140. High Affinity Nerve Growth Factor Receptor Market Drivers
Table 141. High Affinity Nerve Growth Factor Receptor Market Challenges
Table 142. High Affinity Nerve Growth Factor Receptor Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global High Affinity Nerve Growth Factor Receptor Market Size Year-over-Year 2018-2034 & (US$ Million)
Figure 2. Global High Affinity Nerve Growth Factor Receptor Market Size (US$ Million), 2018 VS 2022 VS 2034
Figure 3. Global High Affinity Nerve Growth Factor Receptor Market Share by Regions: 2022 VS 2034
Figure 4. Global High Affinity Nerve Growth Factor Receptor Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 6. Europe High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 7. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 8. Latin America High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 9. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 10. Product Picture of ASP-7962
Figure 11. Global ASP-7962 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 12. Product Picture of AZD-7451
Figure 13. Global AZD-7451 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 14. Product Picture of BNN-27
Figure 15. Global BNN-27 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 16. Product Picture of Cenegermin
Figure 17. Global Cenegermin Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 18. Product Picture of CRB-0089
Figure 19. Global CRB-0089 Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 20. Product Picture of Others
Figure 21. Global Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 22. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Type: 2022 & 2034
Figure 23. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 24. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 25. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 26. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 27. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Type (2018-2034)
Figure 28. Bile Duct Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 29. Papillary Thyroid Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 30. Low Back Pain Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 31. Lung Cancer Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 32. Others Market Size (US$ Million) & YoY Growth (2018-2034)
Figure 33. Global High Affinity Nerve Growth Factor Receptor Market Size Share by Application: 2022 & 2034
Figure 34. North America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 35. Europe High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 36. Asia-Pacific High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 37. Latin America High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 38. Middle East and Africa High Affinity Nerve Growth Factor Receptor Revenue Market Share by Application (2018-2034)
Figure 39. High Affinity Nerve Growth Factor Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 40. Global Top 5 and Top 10 Players High Affinity Nerve Growth Factor Receptor Market Share in 2022
Figure 41. North America High Affinity Nerve Growth Factor Receptor Market Share by Country (2018-2034)
Figure 42. U.S. High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 43. Canada High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 44. Germany High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 45. France High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 46. U.K. High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 47. Italy High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 48. Russia High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 49. Nordic Countries High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 50. Asia-Pacific High Affinity Nerve Growth Factor Receptor Market Share by Region (2018-2034)
Figure 51. China High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 52. Japan High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 53. South Korea High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 54. Southeast Asia High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 55. India High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 56. Australia High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 57. Latin America High Affinity Nerve Growth Factor Receptor Market Share by Country (2018-2034)
Figure 58. Mexico High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 59. Brazil High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 60. Middle East & Africa High Affinity Nerve Growth Factor Receptor Market Share by Country (2018-2034)
Figure 61. Turkey High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 62. Saudi Arabia High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 63. UAE High Affinity Nerve Growth Factor Receptor Market Size (2018-2034) & (US$ Million)
Figure 64. Bottom-up and Top-down Approaches for This Report